Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-17

FDA Approved: GABAPENTIN — Supplemental Application (TIME CAP LABORATORIES, INC)

View source ↗

Summary

FDA approved a supplemental application for gabapentin by Time Cap Laboratories, Inc., resulting in an approved update to the product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)